Biotech Stocks In Focus: Aethlon, Tiziana, Capricor, Firefly & Clearmind

Biotech stocks drew attention Thursday following several company-specific catalysts, led by Aethlon Medical's proposed merger with North Immunology. Other developments included Tiziana Life Sciences' multiple-sclerosis trial collaboration and Capricor's anticipated Duchenne muscular dystrophy data release. The updates could drive individual biotech-share volatility, but no financial terms or clinical data results were provided.